Zips D - Search Results

1

Radiotherapy in nodal oligorecurrent prostate cancer.

Pinkawa M, Aebersold DM, Böhmer D, Flentje M, Ghadjar P, Schmidt-Hegemann NS, Höcht S, Hölscher T, Müller AC, Niehoff P, Sedlmayer F, Wolf F, Zamboglou C, Zips D, Wiegel T. Pinkawa M, et al. Among authors: zips d. Strahlenther Onkol. 2021 Jul;197(7):575-580. doi: 10.1007/s00066-021-01778-1. Epub 2021 Apr 29. Strahlenther Onkol. 2021. PMID: 33914101 Free PMC article. Review.

2

Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation.

Schreiber A, Krause M, Zips D, Dörfler A, Richter K, Vettermann S, Petersen C, Beuthien-Baumann B, Thümmler D, Baumann M. Schreiber A, et al. Among authors: zips d. Strahlenther Onkol. 2004 Jun;180(6):375-82. doi: 10.1007/s00066-004-1206-5. Strahlenther Onkol. 2004. PMID: 15175873

3

Impact of hypoxia and the metabolic microenvironment on radiotherapy of solid tumors. Introduction of a multi-institutional research project.

Zips D, Adam M, Flentje M, Haase A, Molls M, Mueller-Klieser W, Petersen C, Philbrook C, Schmitt P, Thews O, Walenta S, Baumann M. Zips D, et al. Strahlenther Onkol. 2004 Oct;180(10):609-15. doi: 10.1007/s00066-004-1285-3. Strahlenther Onkol. 2004. PMID: 15480508

4

Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?

Yaromina A, Hölscher T, Eicheler W, Rosner A, Krause M, Hessel F, Petersen C, Thames HD, Baumann M, Zips D. Yaromina A, et al. Among authors: zips d. Radiother Oncol. 2005 Aug;76(2):206-12. doi: 10.1016/j.radonc.2005.06.019. Radiother Oncol. 2005. PMID: 16024121

5

Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.

Schütze C, Dörfler A, Eicheler W, Zips D, Hering S, Solca F, Baumann M, Krause M. Schütze C, et al. Among authors: zips d. Strahlenther Onkol. 2007 May;183(5):256-64. doi: 10.1007/s00066-007-1696-z. Strahlenther Onkol. 2007. PMID: 17497097

6

Prostate cancer: biological dose considerations and constraints in tele- and brachytherapy.

Dörr W, Jaal J, Zips D. Dörr W, et al. Among authors: zips d. Strahlenther Onkol. 2007 Dec;183 Spec No 2:14-5. doi: 10.1007/s00066-007-2006-5. Strahlenther Onkol. 2007. PMID: 18166999 No abstract available.

7

Experimental evaluation of functional imaging for radiotherapy.

Zips D, Yaromina A, Schütze C, Wüllrich K, Krause M, Krause M, Hessel F, Eicheler W, Dörfler A, Brüchner K, Menegakis A, Zhou X, Bergmann R, van den Hoff J, Beuthien-Baumann B, Baumann M. Zips D, et al. Strahlenther Onkol. 2007 Dec;183 Spec No 2:41-2. doi: 10.1007/s00066-007-2016-3. Strahlenther Onkol. 2007. PMID: 18167009 No abstract available.

8

Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

Gillham C, Zips D, Pönisch F, Evers C, Enghardt W, Abolmaali N, Zöphel K, Appold S, Hölscher T, Steinbach J, Kotzerke J, Herrmann T, Baumann M. Gillham C, et al. Among authors: zips d. Radiother Oncol. 2008 Sep;88(3):335-41. doi: 10.1016/j.radonc.2008.05.004. Epub 2008 May 29. Radiother Oncol. 2008. PMID: 18514339

9

The future of IGRT - cost benefit analysis.

Baumann M, Hölscher T, Zips D. Baumann M, et al. Among authors: zips d. Acta Oncol. 2008;47(7):1188-92. doi: 10.1080/02841860802304556. Acta Oncol. 2008. PMID: 18663649 No abstract available.

10

Cancer stem cells and radiotherapy.

Baumann M, Krause M, Thames H, Trott K, Zips D. Baumann M, et al. Among authors: zips d. Int J Radiat Biol. 2009 May;85(5):391-402. doi: 10.1080/09553000902836404. Int J Radiat Biol. 2009. PMID: 19382020 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

332 results

Search Page